Literature DB >> 16281933

Advances in the understanding of the congenital dyserythropoietic anaemias.

Sunitha N Wickramasinghe1, William G Wood.   

Abstract

The congenital dyserythropoietic anaemias (CDAs) are a heterogeneous group of diseases in which the anaemia is predominantly caused by dyserythropoiesis and marked ineffective erythropoiesis; three major (types I, II and III) and several minor subgroups have been identified. Additional information on the natural history of these conditions, the beneficial role of splenectomy in CDA type II and efficacy of interferon-alpha in type I have recently been reported. A disease gene has been localised to a chromosomal segment in the three major types and in CDA type I, a disease gene has been identified (CDANI). Mutations have been detected in both familial and sporadic cases but the predicted protein structure gives few clues as to its function. In both type I and II, there are cases unlinked to the identified localisations, suggesting genetic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16281933     DOI: 10.1111/j.1365-2141.2005.05757.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  27 in total

1.  Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors.

Authors:  Stefani Parmentier; Johannes Schetelig; Kerstin Lorenz; Michael Kramer; Robin Ireland; Ulrich Schuler; Rainer Ordemann; Gabi Rall; Markus Schaich; Martin Bornhäuser; Gerhard Ehninger; Frank Kroschinsky
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 2.  Congenital dyserythropoietic anaemias: new acquisitions.

Authors:  Achille Iolascon; Roberta Russo; Maria Rosaria Esposito; Carmelo Piscopo; Roberta Asci; Luigia De Falco; Francesca Di Noce
Journal:  Blood Transfus       Date:  2010-12-13       Impact factor: 3.443

3.  Stem cell transplantation for congenital dyserythropoietic anemia: an analysis from the European Society for Blood and Marrow Transplantation.

Authors:  Maurizio Miano; Dirk-Jan Eikema; Mahmoud Aljurf; Pieter J Van't Veer; Gülyüz Öztürk; Matthias Wölfl; Frans Smiers; Angsar Schulz; Gerard Socié; Kim Vettenranta; Cristina Diaz de Heredia; Marco Zecca; Johan Maertens; Montserrat Rovira; Jorge Sierra; Duygu Uckan-Cetinkaya; Elena Skorobogatova; Ali Bülent Antmen; Jean-Hugues Dalle; Miroslaw Markiewicz; Rose Marie Hamladji; Vassiliki Kitra-Roussou; Giorgio La Nasa; Gergely Kriván; Amal Al-Seiraihy; Stefano Giardino; Antonio Maria Risitano; Regis Peffault de Latour; Carlo Dufour
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

Review 4.  Chromatin condensation during terminal erythropoiesis.

Authors:  Baobing Zhao; Jing Yang; Peng Ji
Journal:  Nucleus       Date:  2016-08-31       Impact factor: 4.197

5.  Codanin-1 mutations engineered in human erythroid cells demonstrate role of CDAN1 in terminal erythroid maturation.

Authors:  Zachary C Murphy; Michael R Getman; Jaquelyn A Myers; Kimberly N Burgos Villar; Emily Leshen; Ryo Kurita; Yukio Nakamura; Laurie A Steiner
Journal:  Exp Hematol       Date:  2020-10-16       Impact factor: 3.084

6.  Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.

Authors:  Shanshan Chen; Ziwen Guo; Yongbin Ye; Shanhong Yang; Guinian Huang
Journal:  Int J Hematol       Date:  2021-04-29       Impact factor: 2.490

7.  Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship.

Authors:  Achille Iolascon; Roberta Russo; Maria Rosaria Esposito; Roberta Asci; Carmelo Piscopo; Silverio Perrotta; Madeleine Fénéant-Thibault; Loïc Garçon; Jean Delaunay
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

Review 8.  The inherited bone marrow failure syndromes.

Authors:  S Deborah Chirnomas; Gary M Kupfer
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

9.  Congenital dyserythropoietic anemia type 1 with a novel mutation in the CDAN1 gene previously diagnosed as congenital hemolytic anemia.

Authors:  Hisanori Fujino; Sayoko Doisaki; Young-Dong Park; Asahito Hama; Hideki Muramatsu; Seiji Kojima; Shinichi Sumimoto
Journal:  Int J Hematol       Date:  2013-04-19       Impact factor: 2.490

10.  Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene.

Authors:  Eyal Shteyer; Ann Saada; Avraham Shaag; Fida' Aziz Al-Hijawi; Rojette Kidess; Shoshanah Revel-Vilk; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2009-03-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.